Sign in
Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial
Nancy M. Holekamp, MD, FASRS
Updates from the Field
2016
Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2021
Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
2022
Category: Pharmacology